ReviewVaccines2023

Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion.

Maarten Postma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.